Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam Langeveld

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Journal of Inherited Metabolic Disease|June 9, 2020
Cognitive functioning and depressive symptoms in Fabry disease: A follow-up studySimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2007
Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistanceMirjam Langeveld, Karen J M Ghauharali, Hans P Sauerwein, et al.
Parkinsonism & Related Disorders|December 26, 2016
New insights in the neurological phenotype of aceruloplasminemia in Caucasian patientsLena H P Vroegindeweij, Janneke G Langendonk, Mirjam Langeveld, et al.
Orphanet Journal of Rare Diseases|June 3, 2026
Treatment goals for adults with early treated PKU should be determined by evidence-based shared decision making between patients and their medical teamMirjam Langeveld, Sandra Sirrs, Robin Lachman, et al.
Scientific Reports|January 19, 2019
Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry diseaseSimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.
Orphanet Journal of Rare Diseases|January 30, 2020
Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and painSimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.
Molecular Genetics and Metabolism|May 13, 2017
Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry diseaseMaarten Arends, Frits A Wijburg, Christoph Wanner, et al.
The American Journal of Clinical Nutrition|October 27, 2017
No metabolic effects of mustard allyl-isothiocyanate compared with placebo in menMirjam Langeveld, Chong Yew Tan, Maarten R Soeters, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 23, 2020
Determinants of cerebral radiological progression in Fabry diseaseSimon Körver, Maria G F Longo, Marjana R Lima, et al.
Orphanet Journal of Rare Diseases|October 4, 2024
Different diseases, different needs: Patient preferences for gene therapy in lysosomal storage disorders, a probabilistic threshold technique surveyEleonore M Corazolla, Eline C B Eskes, Jorien Veldwijk, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Journal of Inherited Metabolic Disease|June 9, 2020
Cognitive functioning and depressive symptoms in Fabry disease: A follow-up studySimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2007
Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistanceMirjam Langeveld, Karen J M Ghauharali, Hans P Sauerwein, et al.
Parkinsonism & Related Disorders|December 26, 2016
New insights in the neurological phenotype of aceruloplasminemia in Caucasian patientsLena H P Vroegindeweij, Janneke G Langendonk, Mirjam Langeveld, et al.
Orphanet Journal of Rare Diseases|June 3, 2026
Treatment goals for adults with early treated PKU should be determined by evidence-based shared decision making between patients and their medical teamMirjam Langeveld, Sandra Sirrs, Robin Lachman, et al.
Scientific Reports|January 19, 2019
Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry diseaseSimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.
Orphanet Journal of Rare Diseases|January 30, 2020
Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and painSimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.
Molecular Genetics and Metabolism|May 13, 2017
Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry diseaseMaarten Arends, Frits A Wijburg, Christoph Wanner, et al.
The American Journal of Clinical Nutrition|October 27, 2017
No metabolic effects of mustard allyl-isothiocyanate compared with placebo in menMirjam Langeveld, Chong Yew Tan, Maarten R Soeters, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 23, 2020
Determinants of cerebral radiological progression in Fabry diseaseSimon Körver, Maria G F Longo, Marjana R Lima, et al.
Orphanet Journal of Rare Diseases|October 4, 2024
Different diseases, different needs: Patient preferences for gene therapy in lysosomal storage disorders, a probabilistic threshold technique surveyEleonore M Corazolla, Eline C B Eskes, Jorien Veldwijk, et al.
Pageof 8